home / stock / ocgn / ocgn news


OCGN News and Press, Ocugen, Inc. From 04/02/24

Stock Information

Company Name: Ocugen, Inc.
Stock Symbol: OCGN
Market: NYSE

Menu

OCGN OCGN Quote OCGN Short OCGN News OCGN Articles OCGN Message Board
Get OCGN Alerts

News, Short Squeeze, Breakout and More Instantly...

OCGN - Ocugen (OCGN) Q4 2023 Earnings Call Transcript

2024-04-02 19:00:11 ET Image source: The Motley Fool. Ocugen (NASDAQ: OCGN) Q4 2023 Earnings Call Apr 02, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Ocugen (OCGN) Q4 2023 Earnings Call Transcript

OCGN - Ocugen slips as accounting errors force restatements

2024-04-02 11:19:08 ET More on Ocugen Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues Ocugen shares make gains after US court dismisses class action lawsuits Ocugen hits a 52-week high after decision to lower quorum requirement...

OCGN - HUT, CXAI and BDRX among pre-market losers

2024-04-02 08:37:57 ET More on Pre-market losers & stocks. Hut 8 Mining Corp. (HUT) Q4 2023 Earnings Call Transcript From Bull To Bear: Recent Events Drove Me To Exit My Position In HUT 8 Hut 8 Post-Merger Comprehensive Thesis: JCapital Research Might Be Right ...

OCGN - Ocugen Provides Business Update with Certain Financials for the Year Ending 2023

Received alignment with FDA for broad retinitis pigmentosa (RP) indication in Phase 3 clinical trial of OCU400—first gene therapy program to receive a broad indication for RP. OCU400 Phase 3 clinical trial expected to commence in April 2024. Regenerative Medicine Advanced Therapy (...

OCGN - Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST-a Modifier Gene Therapy-in GARDian Study for Stargardt Disease

Established Low Dose as Safe and Tolerable Dose in Current OCU410ST Clinical Trial DSMB Determination to Proceed with Medium Dose Cohort Dosing MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused o...

OCGN - Ocugen to Host Conference Call on Tuesday, April 2 at 8:30 A.M. ET to Provide Business Update with Certain Financials for the Year Ending 2023

MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that it will host a conference call and live webcast to...

OCGN - Expected US Company Earnings on Tuesday, March 26th, 2024

Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...

OCGN - Future Penny Stocks Investing Trends, 3 To Consider

2024-03-25 06:09:00 ET 3 Future Penny Stocks Investing Trends to Consider in 2024 Penny stocks represent a unique segment of the market, offering high potential returns to investors willing to navigate its volatility. Trading penny stocks in 2024 requires an understanding of emerging tr...

OCGN - 3 Penny Stocks Trading Mistakes That New and Old Investors Make

2024-03-24 06:24:00 ET 3 Top Penny Stocks Trading Mistakes to Avoid in 2024 Trading penny stocks offers a unique opportunity for both new and seasoned investors to diversify their portfolios and potentially reap significant returns. However, the journey to successful penny stock investm...

OCGN - Biggest stock movers today: FDX, NKE, and more

2024-03-22 05:59:02 ET More on related stocks Reddit: A Robust Growth Prospect With Fuel Behind It FedEx Corporation (FDX) Q3 2024 Earnings Call Transcript NIKE, Inc. (NKE) Q3 2024 Earnings Call Transcript FedEx in charts: U.S. package volume slips from last ...

Previous 10 Next 10